TGF-β / Smad Signaling
Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that regulates proliferation, migration, differentiation, and survival of many different cell types. Deletion or mutation of different members of the TGF-β family have been shown to cause vascular remodeling defect and absence of mural cell formation, leading to embryonic lethality or severe vascular disorders. TGF-β induces smooth muscle differentiation via Notch or SMAD2 and SMAD3 signaling in ES cells or in a neural crest stem cell line. TGF-β binds to TGF-βRI and to induce phosphorylation of SMAD2/3, thereby inhibiting proliferation, tube formation, and migration of endothelial cells (ECs).
TGF-β is a pluripotent cytokine with dual tumour-suppressive and tumour-promoting effects. TGF-β induces the epithelial-to-mesenchymal transition (EMT) leading to increased cell plasticity at the onset of cancer cell invasion and metastasis.
Targets for TGF-β / Smad Signaling
Products for TGF-β / Smad Signaling
- Cat.No. Product Name Information
-
GC17901
Tamoxifen
Tamoxifen(TAM) serves as a selective estrogen receptor regulator (SERM), inhibiting estrogen's effects in breast cells while potentially stimulating estrogen activity in cells found in different tissues.
-
GC10682
TAS 301
inhibitor of smooth muscle cell migration and proliferation, inhibits PKC signaling
-
GC11181
Thiazovivin
Tzv
ROCK inhibitor -
GC73226
THK01
THK01 is a potent ROCK2 inhibitor with IC50 values of 5.7 and 923 nM for ROCK2 and ROCK1, respectively.
-
GC73292
THRX-144644
THRX-144644 is a Lung-restricted ALK5 inhibitor with an IC50 value of 0.14 nM.
-
GC26000
TP0427736 HCl
TP0427736 is a potent inhibitor of ALK5 kinase activity with an IC50 of 2.72 nM and this effect is 300-fold higher than the inhibitory effect on ALK3 (IC50 = 836 nM for ALK3). It also inhibits Smad2/3 phosphorylation in A549 cells induced by TGF-β1 with an IC50 value of 8.68 nM.
-
GC70050
Trabedersen
AP 12009
Trabedersen (AP 12009) is an antisense oligodeoxynucleotide that specifically inhibits TGF-β2 (TGF-beta/Smad). Trabedersen can be used to study malignant brain tumors and other solid tumors that overexpress TGF-β2, such as skin, pancreatic, and colon tumors.
-
GC73087
Trabedersen sodium
AP 12009 sodium
Trabedersen sodium is an antisense oligodeoxynucleotide that specifically inhibits TGF-β2 (TGF-beta/Smad). -
GC40928
Trimethylamine N-oxide
TMAO
Trimethylamine N-oxide (TMAO) is a product of the oxidation of TMA by flavin-containing mono-oxygenase 3 in the liver. -
GC16678
UCN-02
7-epi-hydroxy Staurosporine
protein kinase C inhibitor -
GC37880
Vactosertib Hydrochloride
EW-7197 Hydrochloride; TEW-7197 Hydrochloride
Vactosertib Hydrochloride (EW-7197 Hydrochloride) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib Hydrochloride also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib Hydrochloride has potently antimetastatic activity and anticancer effect. -
GC16934
Valrubicin
NSC 246131, N-Trifluoroacetyladriamycin-14-valerate
chemotherapy drug used to treat bladder cancer -
GC70110
Vamotinib
PF-114
Vamotinib (PF-114) is an effective, selective and orally active tyrosine kinase inhibitor. Vamotinib inhibits the self-phosphorylation of BCR/ABL and BCR/ABL-T315I. Vamotinib induces apoptosis. Vamotinib exhibits anti-proliferative and anti-tumor activity. Vamotinib has potential in the study of resistant Philadelphia chromosome-positive (Ph+) leukemia.
-
GC71894
Vanicoside A
Vanicoside A is a protein kinase C(PKC) inhibitor from Polygonum pensylvanicum.
-
GC13232
Verbascoside
Acteoside, NSC 603831
PKC/NF-κB inhibitor -
GC72283
Vicatertide
Vicatertide is a TGF beta-1 inhibitor.
-
GC31912
VTX-27
VTX-27 is a selective protein kinase C θ (PKC θ) inhibitor, with Kis of 0.08 nM and 16 nM for PKC θ and PKC δ.
-
GC26055
WAY-301398
6-methoxynaphthalene
WAY-301398 (6-methoxynaphthalene) can bind to protein kinase C (PKC). -
GC26065
WAY-354831
WAY-354831 exhibits antibacterial activity.
-
GC10970
WP1130
WP 1130; WP-1130
WP1130 (WP1130) is a cell-permeable deubiquitinase (DUB) inhibitor, directly inhibiting DUB activity of USP9x, USP5, USP14, and UCH37. WP1130 has been shown to downregulate the antiapoptotic proteins Bcr-Abl and JAK2. -
GC62146
XST-14
XST-14 is a potent, competitive and highly selective ULK1 inhibitor with an IC50 of 26.6 nM. XST-14 induces autophagy inhibition by reducing the phosphorylation of the ULK1 downstream substrate. XST-14 induces apoptosis in hepatocellular carcinoma (HCC) cells and has antitumor effects.
-
GC15712
Y-27632
A ROCK inhibitor,potent and selective
-
GC37947
Y-33075
RKI-983, SNJ-1656, Y-39983
Y-33075 is a selective ROCK inhibitor derived from Y-27632, and is more potent than Y-27632, with an IC50 of 3.6 nM. -
GC13423
Y-39983 dihydrochloride
ROCK family inhibitor
-
GC70166
Z-Arg-SBzl
Z-Arg-SBzl is a substrate for activating protein C in both cows and humans.
-
GC71056
Zelasudil
Zelasudil is a Rho-associated (ROCK) kinase inhibitor.
-
GC33120
ZINC00881524
A ROCK inhibitor
-
GC13273
ZIP
ZIP is a selective peptide inhibitor of PKMζ.
-
GC13461
ZIP (SCRAMBLED)
z-Pseudosubstrate inhibitory peptide
PKMζ inhibitor -
GC16510
ZIP, Biotinylated
ZIP with a biotin moiety covalently attached
-
GC14701
Zoledronic Acid
Potent nitrogen-containing bisphosphonates
-
GC17727
[Ala107]-MBP (104-118)
Non-competitive inhibitor of PKC
-
GC15345
[Ala113]-MBP (104-118)
Non-competitive inhibitor of PKC
-
GC10343
α-Amyloid Precursor Protein Modulator
α-Amyloid Precursor Protein Modulator is a cell-permeable benzolactam-derived protein kinase C (PKC) activator with a Ki of 11.9 nM.
-
GC62478
ζ-Stat
NSC37044
ζ-Stat (NSC37044) is a specific and atypical PKC-ζ inhibitor, with an IC50 of 5 μM. ζ-Stat can reduce melanoma cell lines proliferation and induce apoptosis, and has antitumor activity in vitro.